Related Experiment Videos

The effects of perturbed energy metabolism on the processing of amyloid precursor protein in PC12 cells

M T Webster1, B R Pearce, D M Bowen

  • 1Dementia Research Laboratory, Biochemical Neuropharmacology Group, UMDS, London, United Kingdom.

Insights

Alzheimer

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Alzheimer's disease (AD) pathogenesis involves amyloid precursor protein (APP) metabolism, potentially linked to A beta toxicity or reduced neuroprotective APP derivatives.
  • Impaired cellular energy metabolism is a characteristic feature of AD, possibly contributing to APP metabolism imbalance.

Purpose of the Study:

  • To investigate the impact of inhibited oxidative energy metabolism on APP-like protein processing in PC12 cells.
  • To explore potential therapeutic interventions for AD by examining the role of protein kinase C (PKC) and chloroquine.

Main Methods:

  • PC12 cells were subjected to inhibited oxidative energy metabolism.
  • APP-like protein levels (intracellular and secreted) were measured.
  • Cells were treated with chloroquine and activators of protein kinase C (PKC).

Main Results:

  • Inhibition of energy metabolism significantly reduced intracellular and secreted APP-like proteins.
  • Chloroquine restored intracellular APP-like protein levels.
  • PKC activation completely restored the secretion of APP-like proteins.

Conclusions:

  • Energy-related metabolic stress may alter APP-like protein metabolism, potentially promoting an amyloidogenic pathway in Alzheimer's disease.
  • PKC activation can counteract this potentially pathogenic process, suggesting a therapeutic strategy for AD.
  • Cholinomimetic drugs, by potentially activating PKC, may slow AD progression and improve cognitive function.

Related Concept Videos